Under certain conditions, butyrate reduces autophagic inhibition and cytotoxicity in tumor-associated macrophages (TAMs) by suppressing immunosuppressive molecules such as PD-L1 and IL-10 (Dong et al., 2022). Here, CD274 is linked to neoplasm.